in response to pretreatment with , and simultaneous administration of , 6,6'-methylene bis ( 2,2-dimethyl-4-methane sulphonic acid sodium salt-1,2-dihydroquinoline ) the signs and symptoms of fatty liver degeneration , the tissue , plasma and platelet malondialdehyde concentrations and the ldl serum fraction significantly decreased and hdl serum fraction increased .
C0032105
plasma
C0229671
serum